drugset / Trial / NCT05168735

Ketamine + Mindfulness for Depression

NCT05168735

Phase 1/2 Completed 43 enrolled Rebecca Price
RandomizedParallel-groupDouble-blindTreatment

Summary

In this project, the investigators will administer a single infusion of IV ketamine to depressed patients and randomize the patients to receive either a) usual/typical infusion conditions or b) mindfulness training and exercises in conjunction with the infusion. Investigators will test whether the conjunction of ketamine + mindfulness enhances the reductions in depression following a single ketamine infusion.

Timeline

Start
2022-02-01
Primary completion
2023-08-01
Completion
2023-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous